Wilson disease (WD) 4 is an autosomal recessive disorder caused by defects in the copper-transporting P-type ATPase gene (ATP7B) 5 resulting in accumulation of copper in the liver and the brain (1, 2 ) . The disease is diagnosed on the basis of typical symptoms and conventional biochemical indicators, which include low serum concentrations of ceruloplasmin, increased excretion of urinary copper, and presence of the Kayser-Fleischer (K-F) ring (3 ) . Although the biochemical defects are present from birth, manifestation of WD appears at a median age of 12 to 23 years. Thus, the patients usually remain untreated until they manifest the disease, although adverse effects can be thwarted by the use of chelating agents such as penicillamine and zinc acetate (4, 5 ) .
Unlike most other genetic diseases, WD has an available treatment regimen that provides hope to those pre-disposed to the disease if it is diagnosed at a preclinical stage. Thus, in addition to carrier detection as in other genetic diseases, identification of presymptomatic sibs of the proband in WD-affected families is an important step in management of the disease. Although biochemical assays are well defined for WD, the overlapping range of the parameters between noncarriers and carriers of the mutant allele typical of most of the genetic diseases argues in favor of a molecular diagnostic test to allay any confusion. Without appropriate molecular genetic diagnosis, predisposition for the disease would remain unnoticed in WD-mutant children until they manifest signs of the disease. On the other hand, if these presymptomatic individuals are identified, progression of the disease could be monitored by regular checkups of biochemical indicators for therapeutic intervention at an appropriate time. In addition, carrier information can be used for genetic counseling, which is particularly useful for population groups that encourage and practice consanguinity.
Progress in identifying affected individuals has been made by locating the causal gene (ATP7B) on the long arm of chromosome 13 (6 ) , enabling the use of flanking microsatellite markers to study the transmission of the mutant alleles in siblings of affected individuals by linkage analysis (7, 8 ) . We used polymorphic dinucleotide repeat markers (D13S314, D13S133, and D13S316) to identify 4 unrelated presymptomatic children in WD-affected families (9 ) . Incorrect determination of the mutant allele may occur, however, because these extragenic markers reportedly can recombine with WD loci (e.g., D13S314 at 917 kb upstream and D13S316 at 375 kb downstream of ATP7B) (10 ) . Hence intragenic markers would be the ideal choice to reduce the chances of recombination.
Prevalent mutations in ATP7B have been identified in many population groups (http://www.medicalgenetics. med.ualberta.ca/wilson/index.php). Identifying the mutation in a WD patient, followed by genotyping in the sibs for the same mutation, is the ideal strategy for unequivocal determination of the genotype of the sibs. Most WD mutations are rare, however, with a very low frequency that varies greatly from population to population. Hence, to determine genotype in sibs who do not harbor the prevalent mutations, the optimal choice is to use intragenic SNP markers with high heterozygosity values in the study population. New opportunities are opening up with the discovery of large numbers of single-nucleotide polymorphisms (SNPs) in the human genome that could be used for tracking disease loci, for association studies, or simply as markers for monogenic disorders. To date, limited information is available on the SNPs in ATP7B in any population. In the Indian population, SNPs have been used to construct haplotypes and identify prevalent mutations (11 ) . Recently, an SNP profile for the ATP7B gene became available as part of the HapMap project (http:// www.hapmap.org), but no attempt has yet been made to evaluate SNPs as markers for the WD locus. In addition, HapMap data do not yet include the Indian population (one-sixth of the world population; planning commission report of India: http://planningcommission.nic.in/data/ dt_pophsd.pdf).
We report a comprehensive strategy for determining presymptomatic and carrier sibs of indexed WD patients by analyzing population-specific prevalent mutations and SNP markers, taking the Indian population as a model. In addition to prevalent mutations, we have identified and evaluated the SNP profile of the WD gene in the population of India across different regions, selected SNPs with high heterozygosity, determined the extent of linkage disequilibrium (LD) between SNPs, compared the data with the information available for other population groups in the HapMap project, and assessed the utility of these markers for genotyping carriers and presymptomatic sibs in WD-affected families.
Materials and Methods patients and controls
WD patients, mostly with neurological problems, were examined at the Bangur Institute of Neurology, Kolkata, India, with referrals being made to the Regional Institute of Ophthalmology and the Gastroenterology and Paediatrics Departments, Seth Sukhlal Karnani Memorial Hospital, for ophthalmologic and hepatic cases, respectively. The diagnosis was based (a) clinically on the presence of neurological features such as dystonia, tremor, rigidity, and bradykinesia and/or hepatic features such as signs and symptoms of acute or chronic liver failure, and K-F ring in the cornea and (b) biochemically on low serum ceruloplasmin (Ͻ200 mg/L) and high 24-h urinary copper excretion (Ͼ100 g) (3 ), plus computed tomography and MRI scanning where applicable. Diagnosis was based on the entire profile, and presence or absence of any one feature did not contribute toward diagnosis or exclusion. We collected 323 blood samples from 87 families that included at least 1 patient; 30 were multisibling families. The sibs were also examined clinically for possible subclinical or apparently mild manifestations of the disease, i.e., presence of tremor, rigidity, and bradykinesia and/or hepatic features such as signs and symptoms of jaundice, liver enlargement, and K-F ring. General intelligence levels were examined and any apparent abnormality (such as failing grades, forgetfulness, irrational behavior) noted. The sibs who were suspected to carry the disease in the preclinical stage based on the above examination underwent biochemical tests.
To assess the heterozygosity of the SNPs and evaluate the LD status among those in the general population, we included 1871 samples collected as a part of the Indian Genome Variation project (12 ) . These individuals belonged to 55 distinct ethnic groups inhabiting 6 different geographical regions (north, northeast, east, south, west, and central) of mainland India. Moreover, 54 of the ethnic groups comprise the 4 major linguistic families of the Indian population, namely Indo-European, Dravidian, Tibeto-Burman, and Austro-Asiatic; the remaining 1 group represents a population known to have negroid origin and therefore was treated as an outgroup. We collected samples from individuals unrelated at least to the 1st-cousin level. The internal review committee on research using humans cleared the project after proper review as per the regulations of the Indian Council of Medical Research. A list of the populations, with sample sizes and brief notes on their linguistic and sociocultural backgrounds, is provided in Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol53/issue9.
collection of blood samples and genomic dna preparation
We collected approximately 10.0-mL peripheral blood samples with informed consent from study participants who included WD patients, their family members, and the general population included under the Indian Genome Variation project. We prepared genomic DNA from fresh whole blood using the conventional phenol-chloroform method, followed by ethanol precipitation, after which the DNA was dissolved in TE buffer (10 mmol/L TrisHCl, 0.1 mmol/L EDTA, pH 8.0) (13 ) .
amplification of exons and flanking regions, dna sequencing, and genotyping
We performed PCR to amplify the exons and flanking regions of the WD gene from the DNA of patients using primers (14 ) and PCR conditions as described (11 ) .
The PCR products that were free of contaminating bands due to nonspecific amplification were columnpurified using Qiagen PCR-purification reagent sets (Qiagen). We performed bidirectional sequencing by use of an ABI 3100 DNA sequencer with dye-termination chemistry. We confirmed the nucleotide changes in the DNA samples from one of the parents of the proband. We carried out genotyping of the SNPs in the general population by allele-specific primer extension followed by MALDI-TOF mass spectrometry using the Sequenom mass array system, as a part of the Indian Genome Variation project at the Centre for Genomic Application (New Delhi, India).
statistical analysis
We detected novel nucleotide changes by comparing the sequence obtained in the chromatogram with the normal gene sequence (NT_024524; Homo sapiens chromosome 13 genomic contig) using pairwise BLAST (15 ) . We computed allele frequencies and heterozygosities at each variant site by the genotype-counting method. Coefficients of pairwise LD (r 2 ) were estimated using Haploview version 3.32 (16 ) .
Results
We screened 87 unrelated WD patients for nucleotide variants in the ATP7B gene. In addition to 4 prevalent mutations previously identified (11 ), we detected a mutation (c.3182 GϾA/p.Gly1061Glu) accounting for 11% of the WD chromosomes in our patient pool. A comprehensive list of the prevalent mutations in different populations is provided in Table 1 .
In addition, we identified 24 innocuous allelic variants apparently not causal to the disease in 82 WD patients (see Table 2 in the online Data Supplement). First, we estimated the frequencies of the allelic variants for each SNP, and only those with relatively higher minor allele frequencies (Ͼ0.25) were selected. The 4 SNPs (c.1216 TCTϾGCT/p.Ser406Ala, c.2495 AAGϾAGG/p.Lys832Arg, c.2855 AGAϾAAA/p. Arg952Lys, and c.1544-53AϾC) thus picked were observed to have high heterozygosity across various linguistic groups of India (Table 2) . Interestingly, although Austro-Asiatic groups are exclusively endogamous and tribes are dispersed in small inbreeding groups in central and eastern India, the heterozygosities of all the SNPs were high, ranging from 0.41 to 0.481.
To investigate the utility of the SNPs as markers in different populations, we also checked the allele frequency and heterozygosity of the variants in the 4 HapMap project populations, namely Utah residents with ancestry from northern and western Europe (CEU, CEPH), Han Chinese in Beijing, China (CHB), Japanese in Tokyo, Japan (JPT), and Yoruba in Ibadan, Nigeria (YRI). The allele frequencies of the 4 SNPs in these populations are illustrated in Fig. 1 . It is evident that, for all the SNPs, the minor allele frequency is high enough to yield high heterozygosity in all the populations except YRI, in which the G allele for the SNP c.1216 TCTϾGCT shows a low frequency of 0.09 and overall low heterozygosity (0.169; Table 2 ). Interestingly, the minor allele frequencies for the SNPs c.2495 AAGϾAGG and c.2855 AGAϾAAA are identical in 3 of the 4 HapMap populations, CEU, CHB, and JPT. Both Han Chinese and Japanese are members of the larger mongoloid population, but a difference was evident in the heterozygosity of 2 SNPs, c.1216 TCTϾGCT (0.444 vs 0.568) and c.1544-53AϾC (0.378 vs 0.545).
A set of SNPs would be most applicable as markers if the LD between them were low, i.e., the 2 SNPs independently segregate in the population and hence can exclusively serve as markers. In cases in which the 2 SNPs show high LD, either one suffices for the other. LD plots were constructed for the 4 different HapMap populations and the Indian population consisting of 55 ethnic groups. As shown in Fig. 2 , the SNPs were denoted as follows: c.2855 AGAϾAAA (p.Arg952Lys), SNP1; c.2495 AAGϾAGG (p.Lys832Arg), SNP2; c.1544-53AϾC, SNP3; and c.1216 TCTϾGCT (p.Ser406Ala), SNP4. The best possible combinations for the SNPs to be used as markers were determined based on the r LDs (r 2 values), we propose a comprehensive strategy for identification of presymptomatic and carrier sibs of WD patients, through which the potential problem of recombination due to large distance of the microsatellite markers (i.e., 375-917 kb flanking the ATP7B gene) can be avoided (Fig. 3) . To test the usefulness of these SNP markers in our patient pool, we tested 45 offspring from 17 of the 30 multisibling families with 1 proband each. Ten of these 17 patients were found to harbor diseasecausing mutations-IVS4-1GϾC, p.G1061E, p.Y187X, p.C271X, c.892delC, p.G710S, and c.448_452del5-in either homozygous or compound heterozygous condition before SNP genotyping. We determined the genotypes at the SNP markers in 28 individuals who were sibs to the 17 unrelated WD patients in addition to screening of prevalent mutations. We confirmed genotyping for the SNP markers by bidirectional sequencing and Mendelian pattern of inheritance within the family. Thus, as shown in Table 3 , it was found that among the sibs of the patients, 14 were heterozygous for the mutant chromosome (i.e., carrier), 6 children lacking any sign or symptoms of the disease had 2 copies of the same mutant chromosomes as the affected sib (presymptomatic), and 5 children did not harbor a mutant chromosome (genotypically normal). In 3 children (approximately 11% of the test samples), SNPbased diagnosis could not distinguish between the carriers and those harboring no mutant allele (Table 3 ). This anomaly was resolved by using the microsatellite marker D13S133. (17 ) . In general, the Indian population can be, to a large extent, substructured on the basis of ethnic origin as well as linguistic lineage. Of India's 4 major language families, Indo-European and Dravidian languages are spoken in the northern and southern parts of the subcontinent, respectively (18 ); Tibeto-Burman speakers, concentrated in the northern and northeastern parts of the country, are supposed to have immigrated to India from Burma (now, Myanmar) and Tibet (19 ) ; and Austro-Asiatic speakers are exclusively tribes and are dispersed mostly in the central and eastern parts of the country. We extended our study to find the heterozygosities and LDs among the selected SNP markers in 55 populations selected on the basis of their linguistic lineage and geographic location.
Therefore, the present study modeled on the Indian population has a worldwide applicability. The SNPs selected as markers in the Indian population have also been checked in all the HapMap populations. High heterozygosity of the 4 SNPs in all populations suggests that these SNPs are evolutionarily old enough and hence can probably be used as markers worldwide. The LD values (r 2 ) among the 4 SNPs based on the data from 4 linguistic groups of India and HapMap populations suggest that SNPs 1 and 2 (i.e., c.2495 AAGϾAGG and c.2855 AAAϾAGA, respectively) share a high LD among them. The lower the r 2 value between 2 SNPs, the better are the chances of using them individually as markers. Hence either SNP1 or SNP2 can serve as a marker in combination with SNP3 and SNP4. Incidentally, SNPs 3 and 4 in ATP7B alter the restriction sites for BtsCI and AciI, respectively. Therefore, genotyping of these 2 SNPs can easily be done by restriction fragment length polymorphism analysis instead of DNA sequencing.
The general strategy to diagnose a sib of a WD patient as carrier, presymptomatic, or normal begins with screening for the WD mutations prevalent in the population, followed by typing the recommended SNPs in the family to understand the chromosomal segregation. In rare cases, if all the SNPs are found to be uninformative, microsatellite markers could be genotyped in the family to diagnose the sib of a WD patient. Once WD predisposition is identified in an individual, regular checkups, suitable nutrition, and preventive medication should be recommended to thwart disease progression and onset. Families affected with the disease should be encouraged to undergo carrier detection and given genetic counseling as appropriate.
The strategy using intragenic SNPs for diagnosis is highly specific because of the extremely low chances of recombination between the mutation and the SNP marker and is highly sensitive because of the high frequency of the selected markers throughout most world populations. A similar approach can be adopted for other inherited disorders for which prevalent mutations and informative markers are available in the public domain.
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